mitoxantrone has been researched along with Dysplastic Nevus Syndrome, Hereditary in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant melanoma is a skin cancer characterized by rapid development, poor prognosis and high mortality." | 5.72 | Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines-An Isobolographic Analysis. ( Góralczyk, A; Grabarska, A; Marzęda, P; Wróblewska-Łuczka, P; Łuszczki, JJ, 2022) |
| "Malignant melanoma is a skin cancer characterized by rapid development, poor prognosis and high mortality." | 1.72 | Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines-An Isobolographic Analysis. ( Góralczyk, A; Grabarska, A; Marzęda, P; Wróblewska-Łuczka, P; Łuszczki, JJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wróblewska-Łuczka, P | 2 |
| Grabarska, A | 1 |
| Góralczyk, A | 2 |
| Marzęda, P | 1 |
| Łuszczki, JJ | 2 |
2 other studies available for mitoxantrone and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines-An Isobolographic Analysis.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cisplatin; Docetaxel; Humans; Melanoma; Melanoma | 2022 |
Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs.
Topics: Cisplatin; Coumarins; Cytostatic Agents; Docetaxel; Epirubicin; Humans; Melanoma; Melanoma, Cutaneou | 2023 |